Endocrinology and Nutrition Service, Department of Medicine, Germans Trias i Pujol Research Institute and Hospital, Universitat Autònoma de Barcelona, Badalona, Spain.
Department of Endocrinology, Hospital Universitario de La Princesa, Instituto de Investigación de La Princesa, Universidad Autónoma de Madrid, Madrid, Spain.
Rev Endocr Metab Disord. 2022 Apr;23(2):137-150. doi: 10.1007/s11154-021-09678-6. Epub 2021 Jul 31.
Although SARS-CoV-2 viral attacks starts by the interaction of spike protein (S Protein) to ACE2 receptor located at the cell surface of respiratory tract and digestive system cells, different endocrine targets, endocrine organs and metabolic conditions are of fundamental relevance for understanding disease progression and special outcomes, in particular those of fatal consequences for the patient. During pandemic, moreover, a specific phenotype of COVID-19 metabolic patient has been described, characterized by being at particular risk of worse outcomes. In the present paper we describe the mechanism of viral interaction with endocrine organs, emphasizing the specific endocrine molecules of particular relevance explaining COVID-19 disease evolution and outcomes.
虽然 SARS-CoV-2 病毒攻击是由位于呼吸道和消化系统细胞表面的刺突蛋白(S 蛋白)与 ACE2 受体相互作用引起的,但不同的内分泌靶标、内分泌器官和代谢状况对于理解疾病进展和特殊结果(特别是对患者有致命后果的结果)至关重要。此外,在大流行期间,已经描述了 COVID-19 代谢患者的一种特定表型,其特征是处于更糟糕结果的特殊风险中。在本文中,我们描述了病毒与内分泌器官相互作用的机制,强调了特别相关的特定内分泌分子,这些分子解释了 COVID-19 疾病的演变和结果。